BeyondSpring (BYSI)
(Delayed Data from NSDQ)
$2.18 USD
+0.02 (0.92%)
Updated May 3, 2024 09:30 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BYSI 2.18 +0.02(0.92%)
Will BYSI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BYSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BYSI
Clene Inc. (CLNN) Reports Q2 Loss, Lags Revenue Estimates
Humanigen Inc. (HGEN) Reports Q2 Loss, Lags Revenue Estimates
BYSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates
Codexis (CDXS) Surges 9.7%: Is This an Indication of Further Gains?
VistaGen Therapeutics, Inc. (VTGN) Reports Q4 Loss, Misses Revenue Estimates
Other News for BYSI
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
BeyondSpring GAAP EPS of -$0.54, revenue of $1.75M
BeyondSpring GAAP EPS of -$0.54, revenue of $1.75M
BeyondSpring GAAP EPS of -$1.64, revenue of $1.35M
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results